MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring.

The majority of pathogenic mitochondrial DNA (mtDNA) mutations are heteroplasmic, with both mutant and wild-type alleles present within the same individual. MtDNA is transmitted only from females to their offspring but a single female can bear offspring who harbour different levels of mutant mtDNA and have a variable phenotype. In single families, this complex genetic and phenotypic variability has confounded the identification of any relationship between the level of mutant mtDNA (mutation load) in the mother and the clinical features of her offspring. To obtain a more accurate description of the inheritance of pathogenic mtDNA mutations, we studied a large number of pedigrees that carried either the mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (A3243G MELAS) or the myoclonic epilepsy with ragged-red fibres (A8344G MERRF) mutations. We made two principal observations. First, for both mutations, higher levels of mutant mtDNA in the mothers' blood were associated with an increased frequency of affected offspring. Secondly, at any one level of maternal mutation load there was a greater frequency of affected offspring for the A3243G MELAS mutation than for the A8344G MERRF mutation. Although these results should not be used to give absolute risks to a female contemplating pregnancy, they suggest that the outcome of pregnancy is related to the level of mutant mtDNA in the mother and that the risks of having affected offspring may differ between different mtDNA mutations.

[1]  E. Shoubridge,et al.  Pedigree analysis of French Canadian families with T14484C Leber's hereditary optic neuropathy , 1998, Neurology.

[2]  D. Turnbull,et al.  Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. , 1997, Trends in genetics : TIG.

[3]  D. Turnbull,et al.  Clinical features, investigation, and management of patients with defects of mitochondrial DNA , 1997, Journal of neurology, neurosurgery, and psychiatry.

[4]  D. Turnbull,et al.  Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. , 1997, Brain : a journal of neurology.

[5]  A. Schapira,et al.  Genetic counselling in mitochondrial diseases. , 1997, Current opinion in neurology.

[6]  S. Dimauro,et al.  Mitochondrial DNA Mutations and Pathogenesis , 1997, Journal of bioenergetics and biomembranes.

[7]  S. Dimauro,et al.  Mitochondrial DNA and RNA processing in MELAS , 1996, Annals of neurology.

[8]  S. Servidei.  Mitochondrial encephalomyopathies: Gene mutation , 1996, Neuromuscular Disorders.

[9]  N. Chu,et al.  Random mitotic segregation of mitochondrial DNA in MELAS syndrome , 1996, Acta neurologica Scandinavica.

[10]  K. Wakabayashi,et al.  Quantitation of heteroplasmy of mitochondrial trnaLeu(UUR) gene using PCR‐SSCP , 1995, Muscle & nerve.

[11]  E. Holme,et al.  Ekbom's syndrome of photomyoclonus, cerebellar ataxia and cervical lipoma is associated with the tRNALys A8344G mutation in mitochondrial DNA , 1995, Acta neurologica Scandinavica.

[12]  A. Harding,et al.  Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. , 1995, American journal of human genetics.

[13]  A. Harding,et al.  The mitochondrial DNA transfer RNALeu(UUR) A-->G(3243) mutation. A clinical and genetic study. , 1995, Brain : a journal of neurology.

[14]  K. Majamaa,et al.  Demyelinating polyneuropathy in a patient with the tRNALeu(uur) mutation at base pair 3243 of the mitochondrial DNA , 1995, Neurology.

[15]  G. Attardi,et al.  Complementation and segregation behavior of disease-causing mitochondrial DNA mutations in cellular model systems. , 1995, Biochimica et biophysica acta.

[16]  E. Holme,et al.  Inheritance and expression of mitochondrial DNA point mutations. , 1995, Biochimica et biophysica acta.

[17]  J. Enríquez,et al.  MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNALys and premature translation termination , 1995, Nature Genetics.

[18]  J. Arenas,et al.  Clinical heterogeneity in two pedigrees with the 3243 bp tRNALeu(UUR) mutation of mitochondrial DNA , 1995, Acta neurologica Scandinavica.

[19]  J. Aprille,et al.  Familial recurrence of atypical symptoms in an extended pedigree with the syndrome of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). , 1994, The Journal of pediatrics.

[20]  Y. Jong,et al.  MELAS syndrome: correlation between clinical features and molecular genetic analysis , 1994, Acta neurologica Scandinavica.

[21]  W. Ruitenbeek,et al.  Extreme variability of clinical symptoms among sibs in a MELAS family correlated with heteroplasmy for the mitochondrial A3243G mutation , 1994, Journal of the Neurological Sciences.

[22]  H. C. Lee,et al.  MELAS syndrome with mitochondrial tRNA(Leu(UUR)) gene mutation in a Chinese family. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[23]  J. Lloreta,et al.  Myo‐leukoencephalopathy in twins: Study of 3243‐myopathy, encephalopathy, lactic acidosis, and strokelike episodes mitochondrial DNA mutation , 1994, Annals of neurology.

[24]  P. Matthews,et al.  Comparison of the relative levels of the 3243 (A-->G) mtDNA mutation in heteroplasmic adult and fetal tissues. , 1994, Journal of medical genetics.

[25]  G. Silvestri,et al.  MELAS point mutation with unusual clinical presentation , 1993, Neuromuscular Disorders.

[26]  S. Dimauro,et al.  Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA , 1993, Neuromuscular Disorders.

[27]  P. Mazzarello,et al.  Myoclonus epilepsy and ragged‐red fibers: blood mitochondrial DNA heteroplasmy in affected and asymptomatic members of a family , 1993, Acta neurologica Scandinavica.

[28]  S. Dimauro,et al.  Clinical features associated with the A → G transition at nucleotide 8344 of mtDNA (“MERRF mutation”) , 1993, Neurology.

[29]  S. M. Sumi,et al.  Phenotypic heterogeneity in families with the myoclonic epilepsy and ragged‐red fiber disease point mutation in mitochondrial DNA , 1993, Annals of neurology.

[30]  A. Harding,et al.  The mitochondrial DNA transfer RNA(Lys)A-->G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. , 1993, Brain : a journal of neurology.

[31]  S. Tsuji,et al.  Uniform tissue distribution of tRNALys mutation in mitochondrial DNA in MERRF patients , 1993, Neurology.

[32]  K. Majamaa,et al.  Adult‐onset diabetes mellitus and neurosensory hearing loss in maternal relatives of MELAS patients in a family with the tRNALeu(UUR) mutation , 1993, Neurology.

[33]  S. Dimauro,et al.  The syndrome of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes presenting without stroke. , 1993, Archives of neurology.

[34]  M. Pembrey,et al.  Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA , 1992, The Lancet.

[35]  S. Dimauro,et al.  Correlation between clinical and molecular features in two MELAS families , 1992, Journal of the Neurological Sciences.

[36]  E. Holme,et al.  Segregation and manifestations of the mtDNA tRNA(Lys) A-->G(8344) mutation of myoclonus epilepsy and ragged-red fibers (MERRF) syndrome. , 1992, American journal of human genetics.

[37]  S. Dimauro,et al.  MELAS: Clinical features, biochemistry, and molecular genetics , 1992, Annals of neurology.

[38]  N. Romero,et al.  Genetic biochemical and pathophysiological characterization of a familial mitochondrial encephalomyopathy (MERRF) , 1991, Journal of the Neurological Sciences.

[39]  N. Bresolin,et al.  In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. , 1991, Molecular and cellular biology.

[40]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[41]  D. Wallace,et al.  Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation , 1990, Cell.

[42]  C. Erhardt,et al.  INTERPRETATION AND USES OF MEDICAL STATISTICS , 1970 .

[43]  D. Turnbull,et al.  Mitochondrial medicine. , 1997, QJM : monthly journal of the Association of Physicians.

[44]  N. Larsson,et al.  Molecular genetic aspects of human mitochondrial disorders. , 1995, Annual review of genetics.

[45]  後藤 雄一,et al.  The 8,344 mutation in mitochondrial DNA: A comparison between the proportion of mutant DNA and clinico-pathologic findings , 1995 .